RITA ADHIKARI: Open Payments
NPI 1033825161 · PALM BEACH GARDENS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,511 in 75 payments from 17 companies in 2025. Trend: 2023 $670 · 2024 $1,235 · 2025 $1,511
Food & beverage: $1,511
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $354 |
| Merck Sharp & Dohme LLC | 9 | $160 |
| AstraZeneca Pharmaceuticals LP | 7 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $117 |
| Amgen Inc. | 6 | $107 |
| E.R. Squibb & Sons, L.L.C. | 5 | $98 |
| BridgeBio Pharma, Inc. | 4 | $90 |
| Novo Nordisk Inc | 3 | $62 |
| Lilly USA, LLC | 3 | $59 |
| Boston Scientific Corporation | 3 | $54 |
Products named: LEQVIO, VERQUVO, Kerendia, FARXIGA, REPATHA, Attruby, CAMZYOS, Wegovy.
Industry payments across FL — which companies pay providers there.
